in in vitro experiments 20 mg methylprednisolone sodium succinate ( solu-medrol ) per ml plasma significantly inhibited activation of plasma prekallikrein , prothrombin and plasminogen and reduced functional plasma kallikrein inhibition , antithrombin and antiplasmin activities .
C0700546
methylprednisolone
C0701466
solu-medrol